Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Problems of levodopa treatment.

M W Horstink

    Clinical Neurology and Neurosurgery
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    This review covers levodopa therapy side-effects in Parkinson's disease, discussing pharmacokinetics, adverse events, and treatment options. Individual patient factors are crucial for personalized therapeutic recommendations.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome.

    Neurology·2008
    Same author

    ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease.

    Neurology·2007
    Same author

    Startle responses in Parkinson patients during human gait.

    Experimental brain research·2005
    Same author

    Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes.

    Neurology·2005
    Same author

    Intermediate CAG repeat lengths (53,54) for MJD/SCA3 are associated with an abnormal phenotype.

    Annals of neurology·2001
    Same author

    The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism.

    European journal of nuclear medicine·2001

    Area of Science:

    • Neurology
    • Pharmacology

    Background:

    • Parkinson's disease is a progressive neurodegenerative disorder.
    • Levodopa is a primary treatment, but its use is associated with side effects.

    Purpose of the Study:

    • To comprehensively review the side effects of levodopa therapy in Parkinson's disease.
    • To discuss pharmacokinetic aspects and therapeutic strategies for managing levodopa-induced side effects.

    Main Methods:

    • Literature review of pharmacokinetic properties of levodopa.
    • Systematic discussion of common and uncommon side effects.
    • Analysis of current therapeutic interventions for managing side effects.

    Main Results:

    • Levodopa's pharmacokinetics influence its efficacy and side effect profile.

    Related Experiment Videos

  • Various side effects, including motor and non-motor symptoms, are associated with levodopa.
  • Treatment options for side effects exist but require individualized patient assessment.

    • Conclusions:

    • Levodopa therapy requires careful management due to its side effect profile.
    • Personalized treatment approaches are essential, considering individual patient characteristics.
    • Further research may refine therapeutic recommendations for levodopa-related side effects.